PF-Atlas › Clinical Trials › NCT04589260

TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis

TD-1058 · Phase 1

Registry ID

NCT04589260

Phase

Phase 1

Status

Terminated

Drug / intervention

TD-1058

Sponsor

Theravance Biopharma

Start

2020-10-15

About this trial

TD-1058 is evaluated in NCT04589260, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Theravance Biopharma. Current status: Terminated.

View NCT04589260 on ClinicalTrials.gov →

Explore related

All TD-1058 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT04589260 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.